MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED)

To assess the efficacy of MK0524 on seasonal allergies.

Completed

Looking for future studies?

Key information

Conditions

Seasonal Allergies Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Nose Diseases Otorhinolaryngologic Diseases Respiratory Hypersensitivity Respiratory Tract Diseases Rhinitis Rhinitis, Allergic Rhinitis, Allergic, Seasonal

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Person has had at least 2 years of seasonal allergies
Person has had a positive skin test to at least 1 of the allergens of the season
Person is a non-smoker

Exclusion criteria

Person has been hospitalized within the last 4 weeks
Person is a female who has had a baby within the last 8 weeks or is still breast-feeding

Treatment and study plan

MK0524

Drug

Sponsors and collaborators

Lead sponsor

Merck Sharp & Dohme LLC

Industry

Registry information

Important dates

Study start: 2003
Primary completion: 2003
Study completion: 2003
First posted: Sep 21, 2007
Registry last updated: Dec 22, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed